Readers share their opinions on some of the most talked-about breast cancer abstracts they’re looking forward to seeing at ESMO 2026.
|Videos|March 9, 2013
Donna Shalala on New Healthcare Reform
Author(s)Donna Shalala, PhD
Donna Shalala, PhD, President, University of Miami, discusses the new healthcare reform in the U.S.
Advertisement
Donna Shalala, PhD, President, University of Miami, discusses the new healthcare reform in the U.S.
Shalala says that the U.S. will have a shortage of primary care providers, but not if advance practice nurses are used properly. The more training that nurses receive, the more likely they are to fit into the new system. There will be a need, Shalala believes, involving doctors, nurses, physicians assistance, pharmacists, and other healthcare professionals, to expand healthcare to 32 million Americans in an affordable way.
<<<
Advertisement
Related to this article
The 510(k) clearance covers an MRI-derived AI risk score for stage I to IIIA disease; the high-risk category carried an HR of 2.81 for recurrence.
The top 5 OncLive TV videos of the week cover insights in multiple myeloma, HR+ breast cancer, CAR T-cell therapy, CLL, and oral SERDs.
Experts spotlight the prostate and bladder cancer presentations they're most excited to see at the 2026 ESMO Congress.
Nunnery and Bond discuss how patients and advocates can navigate second opinions, mental health support, and the long-term effects of cancer treatment.
Read on to see which data are poised to shape clinical discussions and decision-making in lung cancer at the 2026 ESMO Congress in Madrid, Spain.
Invikafusp alfa now holds fast track status across TMB-H solid tumors that progressed after prior therapy, including checkpoint inhibition.
Experts in gynecologic oncology overview top research being presented at the 2026 ESMO Congress.
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
2
VOLGA, DASL-HiCaP Data Highlight Key Genitourinary Cancer Presentations Arriving at ESMO 2026
3
Five Under 5: Top Oncology Videos for the Week of 10/12
4
Japan Approves On-Body Injector for Subcutaneous Isatuximab in Multiple Myeloma
5